Alpha Cognition (Uplisting)
Note: This is NOT an IPO. This is a public offering in conjunction with a NASDAQ uplisting of Alpha Cognition, which previously traded on the OTC. (Incorporated in British Columbia) The Company is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease (“Alzheimer’s disease” or “AD”), for […]
October 28, 2024 Read More